Pfizer’s Covid vaccine is far less successful at blocking infections in young children than in adults and adolescents, a new study shows.
According to a set of New York state data published on medRxiv, the vaccine provided almost no protection against contracting the coronavirus for children aged five to 11, even within a month of receiving their second shot. The vaccine was effective, however, at preventing severe illness and hospitalisation in that age group.
